We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sareum Holdings Plc | LSE:SAR | London | Ordinary Share | GB00BMC3RJ87 | ORD GBP 0.0125 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 25.50 | 25.00 | 26.00 | 25.50 | 25.50 | 25.50 | 26,919 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -3.19M | -0.0469 | -5.44 | 17.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/7/2022 18:09 | Oliver can you add anymore to your comment. We might be on a similar hymn sheet. My tuppence worth (although a couple rather dubious posters on here will dismiss it with venom) is shares inherently hold a relative risk. Thus those purchasing shares can spread their risk accordingly. But given that following the 6th July some are a bit disgruntled to be missing out on dividends in a particular share they may wish to put a 'bit' of their pot into something that has a stake in a drug that has 2 elements having completed phase 2 in solid tumors and a further 2 re oncology in an unknown pathway/s yet. Also that company has 2 further drugs of which 1 is fully funded going forward, the other is similar and will benefit from any clinical tests undertaken....and then there is also another called Aurora flt3 which is quiet. I suspect if the touch paper was lit it wouldn't just be 'yanks'. I await a backlash from a couple trolls here, but then I often think trolls are expending energy for a reason. I mean who trolls their own investments? Regards Steadydanny | criticalthinker1 | |
04/7/2022 16:13 | Yanks will pile in tomorrow! Cost of RNS now paid for! | oliversanvil | |
04/7/2022 16:06 | Fair shout Norma. They even decide to add false statements re previous posts. That's another positive for myself. Their desperation is noteable. | criticalthinker1 | |
04/7/2022 14:02 | Christ in a basket...months since the last rns...geneic and bland as u like...no excitement...share price is dead...see you all at the 28p party in 2048...xxx | gekko2023 | |
04/7/2022 12:47 | The excitement about this over on LSE is certainly not being matched by enthusiasm for the share price to see a rise...xxx | gekko2023 | |
04/7/2022 11:45 | ‘Critical - it is a positive for me as well....rags are ADVFN negative nutters that are employed to destroy a stock...they are predominantly a shorting outfit!’ Hence put them on ignore. People need to starve it of it’s oxygen. 👍 | norma_stitts | |
04/7/2022 11:01 | What we need is all sareumites to tweet the gsk board to tell them they now have 737 and hence the cure for all cancers...they will be so pleased.to.get this news..xxx | gekko2023 | |
04/7/2022 10:35 | Up 0.49% on the day, on this groundbreaking news. What a share...wouldn't want to be out of this at the weekend etc...zx | gekko2023 | |
04/7/2022 09:35 | Share price is starting to fall again...just watch....jam tomorrow . Xx | gekko2023 | |
04/7/2022 09:33 | Yep barkboo totally agree......and right on time....lol... | criticalthinker1 | |
04/7/2022 09:04 | Generic RNS...nothing we didn't know...737 has been on the shelf for an age. Just as likely that GSK hand back 737. Read the RNS. Read it once more. Read it one more time. The acquisition of sierra was driven by its ownership of a later stage drug. Its like saying GSK bought sierra for the vending machines and office furniture. Hope investors are tweeting GSK to tell them they now own 737...that'll show em...xxx see you at the 28p party...xxx | gekko2023 | |
04/7/2022 09:03 | Critical - it is a positive for me as well....rags are ADVFN negative nutters that are employed to destroy a stock...they are predominantly a shorting outfit! | barkbooo | |
04/7/2022 09:00 | Lol. Thw rags! I am expecting more RNSs this week. The very fact that Sareum can release a RNS (as was expected) with reference to GSK ...soon to be Haleon albeit we are a third party but have a slice of one pie is a positive for me. | criticalthinker1 | |
04/7/2022 08:24 | The rags seem to be silent this morning?? lol | barkbooo | |
03/7/2022 09:16 | Sareum, healing the world...filing patents and director share sales.i am feeling positive about my investment. Between now and the end of time, I am sure this will come good! Froth2 has said he plans to cash out in 2 years...even though he pretended he was going to expire in 12 months...but he lost credibility long ago...that tells me we have much longer to go for this to do well...but hold onto those golden tickets everyone..xx | gekko2023 | |
02/7/2022 23:57 | Bring on the 4th jab | horridhenry | |
02/7/2022 21:16 | This was WIP 25 OCTOBER 2020 ...I enjoy reading his posts RE: End of the week25 Oct '20 And then another couple of multipliers such as SRA737 being fast-tracked AND a deal or deals for both Tyk2’s and this could easily be heading north of 50p Let us not forget, we’ve gone up x6 in the last few months on a bit of news, some pieces of the puzzle being aligned. 25p (or Thoth’s old magic 28p) then only needs to double to be nudging 60p. Then it only needs to double again on another RNS, the herds and wombles see the previous rises from 0.25p less than a year ago, see it’s up to 50p/60p and want in. Even then a 20% rise like we’ve seen a few times recently translates to 12p or more onto the SP WIP was right albeit Sierra kept 737 a media blackout. WIP is one of a few posters I give credit to. If you have held here for a while pre the rise which then got dashed but will happen again...what happened to Philboro RMM3383 JONBELL GUNNER68 LOTONNEWS DRZED RV84 BASALDERMAN PHILBORO Their absence is as iff they expected the rise OCTOBER 2020. Then disappeared. Wait for new posters nudging good will with genuine investors here soon. Just watch. Ps it's a strong buy from me. | criticalthinker1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions